Dynamic Metabolic Changes during the First 3 Months after (90)Y-Ibritumomab Tiuxetan Radioimmunotherapy

Objective. To elucidate the time course of tumor metabolism during the first 3 months after (90)Y-ibritumomab tiuxetan radioimmunotherapy (RIT) in patients with refractory malignant lymphoma. Materials and Methods. Seven patients with recurrent follicular lymphoma underwent FDG-PET imaging before an...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Miwako, Momose, Toshimitsu, Koyama, Keitaro, Ichikawa, Motoshi, Kurokawa, Mineo, Ohtomo, Kuni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090517/
https://www.ncbi.nlm.nih.gov/pubmed/25050390
http://dx.doi.org/10.1155/2014/368947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090517/
https://www.ncbi.nlm.nih.gov/pubmed/25050390
http://dx.doi.org/10.1155/2014/368947

Ejemplares similares